London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations

In breve · dalla fonte (EU-Startups)

Di cosa si tratta

Big Picture Bio, a London-based BioTech startup developing AI-designed combination therapies for cancer and other complex diseases, has emerged from stealth with a combined funding round of €2.55 million (£2.2 million). The funding comprises a €1.75 million (£1.5 million) pre-Seed round co-led by Kadmos Capital and Exceptional Ventures, alongside €815k (£700k) in non-dilutive support from […] The post London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations appeared first on EU-Startups .

Anteprima pubblicata dalla testata nel proprio feed. DuoBiz non ripubblica l'articolo né le immagini: per il testo completo, i dati e le dichiarazioni vai alla fonte.